Compounds > letrozole
Page last updated: 2024-10-30

letrozole and Brain Stem Neoplasms

letrozole has been researched along with Brain Stem Neoplasms in 1 studies

Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butt, SR1
Vatandoust, S1
Kleinig, T1
Adams, J1
Basu, S1
Otto, G1
Joshi, R1

Other Studies

1 other study available for letrozole and Brain Stem Neoplasms

ArticleYear
Anti-Ri antibody-associated paraneoplastic brainstem encephalitis successfully treated after treating the underlying malignancy with letrozole.
    Internal medicine journal, 2013, Volume: 43, Issue:5

    Topics: Aged, 80 and over; Antibodies, Anti-Idiotypic; Antineoplastic Agents; Brain Stem Neoplasms; Breast N

2013